Unison Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.92M Buy
10,261
+22
+0.2% +$8.55K 0.28% 47
2026
Q2
$4.08M Buy
10,239
+40
+0.4% +$11.4K 0.28% 43
2026
Q1
$1.78M Buy
10,199
+32
+0.3% +$6.56K 0.13% 72
2025
Q4
$2.61M Buy
10,167
+30
+0.3% +$7.86K 0.23% 53
2025
Q3
$2.65M Buy
10,137
+37
+0.4% +$9.7K 0.24% 52
2025
Q2
$2.48M Hold
10,100
– – 0.28% 53
2025
Q1
$2.68M Buy
+10,100
New +$2.73M 0.34% 48

Other funds holding HUM

Unison Advisors's HUM Position: Q3 2026 in Review

Unison Advisors increased its Humana (HUM) stake by 0.21% in Q3 2026, buying an estimated $8.55K and bringing the position to 10,261 shares worth $3.92M. The position accounts for 0.28% of the portfolio, ranked #47.

Unison Advisors first reported a position in HUM in Q1 2025 and has held it in 7 quarters since. The position peaked at $4.08M in Q2 2026. 995 funds tracked by Wall St. Rank hold HUM as of Q3 2026.

  • Unison Advisors held 10,261 shares of Humana worth $3.92M as of Q3 2026.
  • Unison Advisors bought 22 Humana shares in Q3 2026, an estimated $8.55K.
  • Humana made up 0.28% of Unison Advisors's portfolio in Q3 2026, its #47 holding.
  • Unison Advisors first reported a position in Humana in Q1 2025 and has held it in 7 quarters since.
  • Unison Advisors's Humana position peaked at $4.08M in Q2 2026.
  • 995 funds tracked by Wall St. Rank held Humana as of Q3 2026.

Based on Unison Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.